These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 7010029)

  • 21. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    De Martiis M; Parenzi A; Barlattani A; De Martiis A
    Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.
    Olsson JE; Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson O; Tornberg A
    Stroke; 1980; 11(1):4-9. PubMed ID: 7355429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug; 22(17):71-2. PubMed ID: 6995822
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
    De Schryver EL; Gorter JW; Algra A; van Gijn J
    Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
    [No Abstract]   [Full Text] [Related]  

  • 31. For your stroke-prone patients: a guide to drug treatment.
    Yatsu FM
    Geriatrics; 1980 Feb; 35(2):34-47. PubMed ID: 7356588
    [No Abstract]   [Full Text] [Related]  

  • 32. Transient ischemic attacks: Part II. Treatment.
    Solenski NJ
    Am Fam Physician; 2004 Apr; 69(7):1681-8. PubMed ID: 15086040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating thromboembolic disease.
    Deykin D; Gurewich V; Harker L; Hirsch J
    Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract]   [Full Text] [Related]  

  • 34. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.